GlassScriptPhysician profile
Richard Ferkel
NPI 1831128230
$58,025.68
in general payments reported to CMS, 2019-2025
22 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,744 · 2020: $16K · 2021: $9,312 · 2022: $8,014 · 2023: $1,990 · 2024: $8,120 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $3,157 · Food and Beverage: $3,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,309.38 |
| Travel and Lodging | $3,156.83 |
| Food and Beverage | $3,120.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $44,541.35 | 2019-2025 | Q-Fix, Spatial Frame, Fast-Fix |
| Trice Medical, INC. | $6,973.71 | 2020-2022 | |
| Saxum Surgical, INC. | $1,675.06 | 2022-2025 | |
| Geistlich Pharma, North America, INC. | $1,650.00 | 2020 | |
| Depuy Synthes Sales INC. | $528.36 | 2019-2025 | Twistr, Rigidloop, Healix Advance Dyna+Tape Permatape Dynacord |
| Paragon 28, INC. | $408.50 | 2019-2025 | Portfolio, R3flex |
| Vericel Corporation | $397.00 | 2019-2025 | Maci |
| Arteriocyte Medical Systems, INC. | $263.53 | 2019 | |
| Medshape, INC. | $244.89 | 2022 | |
| Wright Medical Technology, INC. | $243.90 | 2019 | |
| Bioventus LLC | $225.70 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Medartis INC. | $185.85 | 2023-2025 | Aptus |
| Crossroads Extremity Systems, LLC | $147.50 | 2019 | |
| Ossio INC | $131.32 | 2023 | |
| Zimmer Biomet Holdings, INC. | $125.46 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $119.80 | 2019 | |
| Nalu Medical, INC. | $36.52 | 2025 | Nalu Neurostimulation System |
| Linvatec Corporation | $31.69 | 2022 | |
| Elite Orthopedics, LLC | $29.96 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $25.55 | 2025 | |
| Ossur Americas, INC. | $21.51 | 2024 | Miami J |
| Avanos Medical | $18.52 | 2023 | Trivisc Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$351.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ferkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.